SlideShare a Scribd company logo
1 of 1
Download to read offline
Not all genotyping tests predict response or non-response to therapeutics. Refer to respective test package inserts as applicable.
Zanger UM, Klein K, Thomas M, Rieger JK, Tremmel R, Kandel BA, Klein M, Magdy T. Genetics, epigenetics, and regulation of drug-metabolizing cytochrome p450 enzymes. Clin Pharmacol Ther. 2014;95(3):258-61.
Source: P450 Drug Interaction Table. Indiana University School of Medicine. Cited 2014 July. http://medicine.iupui.edu/clinpharm/ddis/clinical-table/
©2014 Luminex Corporation. All rights reserved. The trademarks mentioned herein are the property of Luminex or their respective owners.
Determining CYP450 genotypes can help classify patients into the right metabolizer status.
Poor Metabolizers
In people who process a certain drug more slowly than normal because of a missing enzyme, the
medication can build up in their system. This can increase the likelihood that it will cause side
effects. These people may still be able to benefit from these medications, but at lower dosages.
Normal Metabolizers
People with normal metabolizers are more likely to benefit from treatment and have fewer side
effects.
Intermediate Metabolizers
People with reduced enzyme function in processing drugs may not process some medications as
well as normal metabolizers do. This can increase a risk of side effects and drug interactions.
Ultra-rapid Metabolizers
People in which medications leave the body too quickly, often before they have a chance to work
properly. Physicians may elect to prescribe higher than usual doses of medication(s).
CYP2D6
CYP3A4/A5/A7
Antidepressants:
ELAVIL®
(amitriptyline)
ANAFRANIL®
(clomipramine)
NORPRAMIN®
(desipramine)
CYMBALTA®
(duloxetine)
PROZAC®
(fluoxetine)
TOFRANIL®
(imipramine)
PAXIL®
(paroxetine)
Antipsychotics:
HALDOL®
(haloperidol)
RISPERDAL®
(risperidone)
Beta Blockers:
COREG®
(carvedilol)
TIMOPTIC®
(timolol)
Antihistamines:
CHLOR-TABS®
(chlorpheniramine)
Benzodiazepines:
XANAX®
(alprazolam)
HALCION®
(triazolam)
Calcium Channel Blockers:
NORVASC®
(amlodipine)
CARDIZEM®
(diltiazem)
PLENDIL®
(felodipine)
PROCARDIA®
(nifedipine)
SULAR®
(nisoldipine)
VERELAN®
(verapamil)
HIV Antivirals:
CRIXIVAN®
(indinavir)
NORVIR®
(ritonavir)
FORTOVASE®
(saquinavir)
Macrolide antibiotics:
BIAXIN®
(clarithromycin)
KETEK®
(telithromycin)
PDE-5 Inhibitors:
VIAGRA®
(sildenafil)
LEVITRA®
(vardenafil)
HMG CoA Reductase
Inhibitors:
LIPITOR®
(atorvastatin)
MEVACOR®
(lovastatin)
ZOCOR®
(simvastatin)
Immune Modulators:
RESTASIS®
(cyclosporine)
Other:
VIRAMUNE®
(nevirapine)
CYP1A2
CLOZARIL®
(clozapine)
FLEXERIL®
(cyclobenzaprine)
CYMBALTA®
(duloxetine)
LUVOX®
(fluvoxamine)
HALDOL®
(haloperidol)
TOFRANIL®
(imipramine)
MEXITIL®
(mexiletine)
RELAFEN®
(nabumetone)
ALEVE®
(naproxen)
ZYPREXA®
(olanzapine)
RILUTEK®
(riluzole)
COGNEX®
(tacrine)
THEOLAIR®
(theophylline)
ZANAFLEX®
(tizanidine)
DYRENIUM®
(triamterene)
ZYFLO®
(zileuton)
ZOMIG®
(zolmitriptan)
GLUCOTROL®
(glipizide)
GLYNASE®
(glyburide)
CELEBREX®
(celecoxib)
LESCOL®
(fluvastatin)
DILANTIN®
(phenytoin)
AVANDIA®
(rosiglitazone)
DEMADEX®
(torsemide)
DEPAKENE®
(valproic acid)
COUMADIN®
(warfarin)
ACCOLATE®
(zafirlukast)
Angiotensin Receptor Blockers:
COZAAR®
(losartan)
AVAPRO®
(irbesartan)
NSAIDs:
SOLARAZE®
(diclofenac)
ADVIL®
(ibuprofen)
ALEVE®
(naproxen)
FELDENE®
(piroxicam)
CYP2B6
WELLBUTRIN®
(bupropion)
SUSTIVA®
(efavirenz)
IFEX®
(ifosfamide)
KETALAR®
(ketamine)
DEMEROL®
(meperidine)
METHADOSE®
(methadone)
VIRAMUNE®
(nevirapine)
DIPRIVAN®
(propofol)
ZELAPAR®
(selegiline)
Anti-epileptics:
VALIUM®
(diazepam)
DILANTIN®
(phenytoin)
NEXIUM®
(esomeprazole)
PPIs:
PREVACID®
(lansoprazole)
PRILOSEC®
(esomeprazole)
PROTONIX®
(pantoprazole)
Others:
ELAVIL®
(amitriptyline)
SOMA®
(carisoprodol)
CELEXA®
(citalopram)
ANAFRANIL®
(clomipramine)
PLAVIX®
(clopidogrel)
TOFRANIL®
(imipramine)
TRANDATE®
(labetalol)
PALUDRINE®
(proguanil)
VFEND®
(voriconazole)
CYP2E1
Anesthetics:
ETHRANE®
(enflurane)
FLUOTHANE®
(halothane)
FORANE®
(isoflurane)
PENTHROX®
(methoxyflurane)
ULTANE®
(sevoflurane)
Others:
LORZONE®
(chlorzoxazone)
MICROBAN®
(ethanol)
CYP2C9
CYP2C19 3%
7%
7%
9%
20%
30%
13%
%ofdrugs
metabolized by
CYP450

More Related Content

What's hot

Pharmacogenomics
PharmacogenomicsPharmacogenomics
Pharmacogenomics
shabrelhan
 
Pharmacogenomics
PharmacogenomicsPharmacogenomics
Pharmacogenomics
Nupur Joshi
 

What's hot (20)

Pharmacogenomics as a tool for Personalized medicine
Pharmacogenomics as a tool for Personalized medicinePharmacogenomics as a tool for Personalized medicine
Pharmacogenomics as a tool for Personalized medicine
 
Pharmacogenetics of antipsychotic and antidepressent
Pharmacogenetics of antipsychotic and antidepressentPharmacogenetics of antipsychotic and antidepressent
Pharmacogenetics of antipsychotic and antidepressent
 
Demystifying Pharmacogenetics
Demystifying PharmacogeneticsDemystifying Pharmacogenetics
Demystifying Pharmacogenetics
 
Pharmacogenomics
PharmacogenomicsPharmacogenomics
Pharmacogenomics
 
Pharmacogenomics, Pharmacogenetics and Pharmacokinetics
Pharmacogenomics, Pharmacogenetics and Pharmacokinetics Pharmacogenomics, Pharmacogenetics and Pharmacokinetics
Pharmacogenomics, Pharmacogenetics and Pharmacokinetics
 
Pharmacogenetics and Pharmacogenomics
Pharmacogenetics and PharmacogenomicsPharmacogenetics and Pharmacogenomics
Pharmacogenetics and Pharmacogenomics
 
Pharmacogenomics- a step to personalized medicines
Pharmacogenomics- a step to personalized medicinesPharmacogenomics- a step to personalized medicines
Pharmacogenomics- a step to personalized medicines
 
Personalised Medicine
Personalised MedicinePersonalised Medicine
Personalised Medicine
 
20091109 Biol1010 Personalized Medicine
20091109 Biol1010 Personalized Medicine20091109 Biol1010 Personalized Medicine
20091109 Biol1010 Personalized Medicine
 
Personalized medicine
Personalized medicinePersonalized medicine
Personalized medicine
 
Pharmacogenetics and Pharmacogenomics
Pharmacogenetics and PharmacogenomicsPharmacogenetics and Pharmacogenomics
Pharmacogenetics and Pharmacogenomics
 
Pharmacogenetics and therapeutic drug monitoring practice
Pharmacogenetics and therapeutic drug monitoring practicePharmacogenetics and therapeutic drug monitoring practice
Pharmacogenetics and therapeutic drug monitoring practice
 
Pharmacogenomics
PharmacogenomicsPharmacogenomics
Pharmacogenomics
 
Pharmacogenomics
PharmacogenomicsPharmacogenomics
Pharmacogenomics
 
Pharmacogenomics & its ethical issues
Pharmacogenomics & its ethical  issuesPharmacogenomics & its ethical  issues
Pharmacogenomics & its ethical issues
 
Pharmacology for Physiotherapy Book By Padmaja Udaykumar Second Edition.
Pharmacology for Physiotherapy Book By Padmaja Udaykumar Second Edition.Pharmacology for Physiotherapy Book By Padmaja Udaykumar Second Edition.
Pharmacology for Physiotherapy Book By Padmaja Udaykumar Second Edition.
 
Pharmacogenomic Clinical Studies
Pharmacogenomic Clinical StudiesPharmacogenomic Clinical Studies
Pharmacogenomic Clinical Studies
 
Pharmacogenetics seminar
Pharmacogenetics seminarPharmacogenetics seminar
Pharmacogenetics seminar
 
Grand Rounds Pharmacogenomics
Grand Rounds PharmacogenomicsGrand Rounds Pharmacogenomics
Grand Rounds Pharmacogenomics
 
pharmacogenomics by rajesh .I
pharmacogenomics by rajesh .Ipharmacogenomics by rajesh .I
pharmacogenomics by rajesh .I
 

Similar to PGx Poster

Mental Health PGX Brochure
Mental Health PGX BrochureMental Health PGX Brochure
Mental Health PGX Brochure
julian rayford
 
The-Case-for-Practice-Integration[1]
The-Case-for-Practice-Integration[1]The-Case-for-Practice-Integration[1]
The-Case-for-Practice-Integration[1]
Amy Williams
 
Unnec med use 2010
Unnec med use 2010Unnec med use 2010
Unnec med use 2010
Debbie Ohl
 
10.29.07 Coumadin P Gx Jonas
10.29.07 Coumadin P Gx Jonas10.29.07 Coumadin P Gx Jonas
10.29.07 Coumadin P Gx Jonas
Flavio Guzmán
 
linical pharmacogenomics consists of the appli-cation of res.docx
linical pharmacogenomics consists of the appli-cation of res.docxlinical pharmacogenomics consists of the appli-cation of res.docx
linical pharmacogenomics consists of the appli-cation of res.docx
washingtonrosy
 
linical pharmacogenomics consists of the appli-cation of res.docx
linical pharmacogenomics consists of the appli-cation of res.docxlinical pharmacogenomics consists of the appli-cation of res.docx
linical pharmacogenomics consists of the appli-cation of res.docx
croysierkathey
 

Similar to PGx Poster (20)

Mental Health PGX Brochure
Mental Health PGX BrochureMental Health PGX Brochure
Mental Health PGX Brochure
 
05categories of patients for personalized medicine^.pptx
05categories of patients for personalized medicine^.pptx05categories of patients for personalized medicine^.pptx
05categories of patients for personalized medicine^.pptx
 
The-Case-for-Practice-Integration[1]
The-Case-for-Practice-Integration[1]The-Case-for-Practice-Integration[1]
The-Case-for-Practice-Integration[1]
 
PERSONALIZED MEDICINE AND PHARMACOGENETICS
PERSONALIZED MEDICINE  AND PHARMACOGENETICSPERSONALIZED MEDICINE  AND PHARMACOGENETICS
PERSONALIZED MEDICINE AND PHARMACOGENETICS
 
pharmacogenomicspptnsu-191212202112 (1).pptx
pharmacogenomicspptnsu-191212202112 (1).pptxpharmacogenomicspptnsu-191212202112 (1).pptx
pharmacogenomicspptnsu-191212202112 (1).pptx
 
Personalized medicine
Personalized medicinePersonalized medicine
Personalized medicine
 
Knowledge of Pharmacogenomics.pptx
Knowledge of Pharmacogenomics.pptxKnowledge of Pharmacogenomics.pptx
Knowledge of Pharmacogenomics.pptx
 
PHARMACOGENOMICS AND PRECISION MEDICINE
PHARMACOGENOMICS AND PRECISION MEDICINEPHARMACOGENOMICS AND PRECISION MEDICINE
PHARMACOGENOMICS AND PRECISION MEDICINE
 
Presentation on personalised medicines
Presentation on personalised medicines Presentation on personalised medicines
Presentation on personalised medicines
 
OBJECTIVE 3.pptx
OBJECTIVE 3.pptxOBJECTIVE 3.pptx
OBJECTIVE 3.pptx
 
Pharmacogenomics.pptx
Pharmacogenomics.pptxPharmacogenomics.pptx
Pharmacogenomics.pptx
 
Unnec med use 2010
Unnec med use 2010Unnec med use 2010
Unnec med use 2010
 
Pharmacogenomics
PharmacogenomicsPharmacogenomics
Pharmacogenomics
 
Pharmacogenomics
PharmacogenomicsPharmacogenomics
Pharmacogenomics
 
10.29.07 Coumadin P Gx Jonas
10.29.07 Coumadin P Gx Jonas10.29.07 Coumadin P Gx Jonas
10.29.07 Coumadin P Gx Jonas
 
genetic polymorphism new Presentation.pptx
genetic polymorphism new Presentation.pptxgenetic polymorphism new Presentation.pptx
genetic polymorphism new Presentation.pptx
 
linical pharmacogenomics consists of the appli-cation of res.docx
linical pharmacogenomics consists of the appli-cation of res.docxlinical pharmacogenomics consists of the appli-cation of res.docx
linical pharmacogenomics consists of the appli-cation of res.docx
 
linical pharmacogenomics consists of the appli-cation of res.docx
linical pharmacogenomics consists of the appli-cation of res.docxlinical pharmacogenomics consists of the appli-cation of res.docx
linical pharmacogenomics consists of the appli-cation of res.docx
 
Adverse drug reaction
Adverse drug reactionAdverse drug reaction
Adverse drug reaction
 
Personalized medicine ppt
Personalized medicine pptPersonalized medicine ppt
Personalized medicine ppt
 

PGx Poster

  • 1. Not all genotyping tests predict response or non-response to therapeutics. Refer to respective test package inserts as applicable. Zanger UM, Klein K, Thomas M, Rieger JK, Tremmel R, Kandel BA, Klein M, Magdy T. Genetics, epigenetics, and regulation of drug-metabolizing cytochrome p450 enzymes. Clin Pharmacol Ther. 2014;95(3):258-61. Source: P450 Drug Interaction Table. Indiana University School of Medicine. Cited 2014 July. http://medicine.iupui.edu/clinpharm/ddis/clinical-table/ ©2014 Luminex Corporation. All rights reserved. The trademarks mentioned herein are the property of Luminex or their respective owners. Determining CYP450 genotypes can help classify patients into the right metabolizer status. Poor Metabolizers In people who process a certain drug more slowly than normal because of a missing enzyme, the medication can build up in their system. This can increase the likelihood that it will cause side effects. These people may still be able to benefit from these medications, but at lower dosages. Normal Metabolizers People with normal metabolizers are more likely to benefit from treatment and have fewer side effects. Intermediate Metabolizers People with reduced enzyme function in processing drugs may not process some medications as well as normal metabolizers do. This can increase a risk of side effects and drug interactions. Ultra-rapid Metabolizers People in which medications leave the body too quickly, often before they have a chance to work properly. Physicians may elect to prescribe higher than usual doses of medication(s). CYP2D6 CYP3A4/A5/A7 Antidepressants: ELAVIL® (amitriptyline) ANAFRANIL® (clomipramine) NORPRAMIN® (desipramine) CYMBALTA® (duloxetine) PROZAC® (fluoxetine) TOFRANIL® (imipramine) PAXIL® (paroxetine) Antipsychotics: HALDOL® (haloperidol) RISPERDAL® (risperidone) Beta Blockers: COREG® (carvedilol) TIMOPTIC® (timolol) Antihistamines: CHLOR-TABS® (chlorpheniramine) Benzodiazepines: XANAX® (alprazolam) HALCION® (triazolam) Calcium Channel Blockers: NORVASC® (amlodipine) CARDIZEM® (diltiazem) PLENDIL® (felodipine) PROCARDIA® (nifedipine) SULAR® (nisoldipine) VERELAN® (verapamil) HIV Antivirals: CRIXIVAN® (indinavir) NORVIR® (ritonavir) FORTOVASE® (saquinavir) Macrolide antibiotics: BIAXIN® (clarithromycin) KETEK® (telithromycin) PDE-5 Inhibitors: VIAGRA® (sildenafil) LEVITRA® (vardenafil) HMG CoA Reductase Inhibitors: LIPITOR® (atorvastatin) MEVACOR® (lovastatin) ZOCOR® (simvastatin) Immune Modulators: RESTASIS® (cyclosporine) Other: VIRAMUNE® (nevirapine) CYP1A2 CLOZARIL® (clozapine) FLEXERIL® (cyclobenzaprine) CYMBALTA® (duloxetine) LUVOX® (fluvoxamine) HALDOL® (haloperidol) TOFRANIL® (imipramine) MEXITIL® (mexiletine) RELAFEN® (nabumetone) ALEVE® (naproxen) ZYPREXA® (olanzapine) RILUTEK® (riluzole) COGNEX® (tacrine) THEOLAIR® (theophylline) ZANAFLEX® (tizanidine) DYRENIUM® (triamterene) ZYFLO® (zileuton) ZOMIG® (zolmitriptan) GLUCOTROL® (glipizide) GLYNASE® (glyburide) CELEBREX® (celecoxib) LESCOL® (fluvastatin) DILANTIN® (phenytoin) AVANDIA® (rosiglitazone) DEMADEX® (torsemide) DEPAKENE® (valproic acid) COUMADIN® (warfarin) ACCOLATE® (zafirlukast) Angiotensin Receptor Blockers: COZAAR® (losartan) AVAPRO® (irbesartan) NSAIDs: SOLARAZE® (diclofenac) ADVIL® (ibuprofen) ALEVE® (naproxen) FELDENE® (piroxicam) CYP2B6 WELLBUTRIN® (bupropion) SUSTIVA® (efavirenz) IFEX® (ifosfamide) KETALAR® (ketamine) DEMEROL® (meperidine) METHADOSE® (methadone) VIRAMUNE® (nevirapine) DIPRIVAN® (propofol) ZELAPAR® (selegiline) Anti-epileptics: VALIUM® (diazepam) DILANTIN® (phenytoin) NEXIUM® (esomeprazole) PPIs: PREVACID® (lansoprazole) PRILOSEC® (esomeprazole) PROTONIX® (pantoprazole) Others: ELAVIL® (amitriptyline) SOMA® (carisoprodol) CELEXA® (citalopram) ANAFRANIL® (clomipramine) PLAVIX® (clopidogrel) TOFRANIL® (imipramine) TRANDATE® (labetalol) PALUDRINE® (proguanil) VFEND® (voriconazole) CYP2E1 Anesthetics: ETHRANE® (enflurane) FLUOTHANE® (halothane) FORANE® (isoflurane) PENTHROX® (methoxyflurane) ULTANE® (sevoflurane) Others: LORZONE® (chlorzoxazone) MICROBAN® (ethanol) CYP2C9 CYP2C19 3% 7% 7% 9% 20% 30% 13% %ofdrugs metabolized by CYP450